Meet the Program Commitee for 2026!

Sabine Haubenreisser, PhD, MSc • Principal Scientific Administrator, Stakeholders and Communication Division
European Medicines Agency, Netherlands

Jesper Kjær, MS • Global Director for Public, Private Partnerships, Strat Ops, Global Med Affairs
Novo Nordisk, Denmark

Aimad Torqui • Head of Division European cooperation and veterinary affairs
MEB, Netherlands

Dimitrios Athanasiou, MBA • Patient Advocate
WORLD DUCHENNE ORGANIZATION (WDO) , MDA HELLAS, Greece

Seán Byrne • Senior Manager Legal and Regulatory Affairs
European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), Belgium

Angelika Joos, MPharm • Executive Director, Science & Regulatory Policy
MSD, Belgium

João Duarte, MPharm, MSc • Vice President, Head of Global Regulatory Affairs Excellence
Ipsen, France

Tim Chesworth • Senior Director Regulatory Affairs
Novartis, United Kingdom

Angela Currie • Head of New Product Introduction and Regulatory Intelligence, Operations Regulat
AstraZeneca, United Kingdom

Teresa Eastwood-Kiefer • Global Lead, Regulatory Submission Management
Roche, Switzerland

Rüdiger Faust, DrSc • Global Regulatory Policy and Intelligence Lead
UCB Biosciences GmbH, Germany

Chloe Garay, PharmD • Sr. Director, Global Regulatory Intelligence & Policy
Eli Lilly and Company, United Kingdom

Pedro Franco, PharmD, PhD, MS, MSc • Senior Director for Global Regulatory & Scientific Policy (GRASP)
Merck Serono Limited, United Kingdom

Stuart Finnie, DrSc, MS • Senior Director, CMC RA Policy and Advocacy
Gilead Sciences, United Kingdom

Lene Kirstein, MPharm • Head of Regulatory Science & Policy
H. Lundbeck A/S, Denmark

Martin O'Kane • Regional Head RA EU Policy & Liaison
Novartis Pharmaceuticals, United Kingdom

Susan M Sandler, RPh • Director, Global Regulatory Policy and Intelligence
Johnson & Johnson, United Kingdom

Jens-Ulrich Stegmann, MD, RN • Senior Vice President, Head Clinical Safety and Pharmacovigilance and EU QPPV
GSK , Belgium

Jonathan Sutch, PhD • Principal Medicinal Technical Specialist
BSI Group, United Kingdom

Sarah Vaughan • Head of Vigilance Operations
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

Gabriel Westman, MD, PhD, MSc • Head of Artificial Intelligence
Swedish Medical Products Agency, Sweden

Kathleen Grieve • Director - European Public Policy Access, Pricing and Affordability Policy Lead
MSD Europe Belgium SRL/BV, Belgium

Sini Eskola, MPharm, MS, MSc • Head of International Regulatory Policy and Innovation
Takeda, Belgium

Nick Sykes, MS • Policy Advisor, Regulatory Strategy
EFPIA, Belgium

Marianne Lunzer, DrMed • Assessor, Dept of Clinical Trials, Federal Office for Safety in Health Care
AGES, Austria

Benjamin Gannon • VP international markets
Guardant, United States

Ditte Zerlang Andersen, PhD, MSc • Senior Strategy Project Lead
Danish Medicines Agency (DKMA), Denmark

Clare Baledran • VP Precision medicines
Novo Nordisk, Denmark

Thierry Sirdey • Team lead Innovation and Operational Excellence
ProductLife Group, France

Antonia Morga • Head, New Product Planning, Global Value Evidence
Astellas Pharma Europe Ltd, United Kingdom

Comité del programa